Does the progression of myocardial fibrosis lead to atrial fibrillation in patients with hypertrophic cardiomyopathy?

Cardiovascular Pathology

Volumn 10, Issue 6, 2001, Pages 297-303

  Yamaji, Kunihiro ^a   Fujimoto, Shinichi ^a   Yutani, Chikao ^b   Ikeda, Yoshihiko ^b   Mizuno, Reiko ^a   Hashimoto, Toshio ^a   Nakamura, Shinobu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atrial fibrillation; Fibrosis; Hypertrophic cardiomyopathy

Indexed keywords

ADULT; AGED; ARTERY OCCLUSION; ARTICLE; AUTOPSY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE WALL; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY STENOSIS; DISEASE PROGRESSION; FEMALE; FIBROSIS; HEART VENTRICLES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MYOCARDIUM;

EID: 0035695267     PISSN: 10548807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-8807(01)00086-2     Document Type: Article

References (47)

1. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy
2. Hypertrophic cardiomyopathy. Recent observations regarding the specificity of three hallmarks of the disease: Asymmetric septal hypertrophy, septal disorganization and systolic anterior motion of the anterior mitral leaflet
3. Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation
4. Incidence of ischemic strokes in hypertrophic cardiomyopathy is markedly increased if complicated by atrial fibrillation
5. Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy
6. Pathological analysis of hypertrophic cardiomyopathy simulating dilated cardiomyopathy
7. Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer
8. Computer-assisted morphometric analysis of the heart
9. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts and hearts with hypertrophic cardiomyopathy
10. Morphometric comparison of mitochondria and myofibrils of cardiomyocytes between hypertrophic and dilated cardiomyopathy
11. Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy
12. Relation between marked changes in left ventricular outflow tract gradient and disease progression in hypertrophic cardiomyopathy
13. Transmural myocardial infarction in hypertrophic cardiomyopathy: A cause of conversion from left ventricular asymmetry to symmetry and from normal size to dilated left ventricular cavity
14. Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy
15. Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patients with hypertrophic cardiomyopathy
16. Asymmetrical hypertrophy of the heart in young adults
17. Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries
18. Hypertrophic cardiomyopathy. Clinical spectrum and treatment
19. Triple control of relaxation: Implications in cardiac disease
20. Diastolic failure: Pathophysiology and therapeutic implications
21. Dual control of relaxation: Its role in the ventricular function in the mammalian heart
22. Effect of regional myocardial perfusion abnormalities on regional myocardial early diastolic function in patients with hypertrophic cardiomyopathy
23. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: Pressure-volume analysis with a non-imaging scintillation probe
24. Use of pulsed Doppler tissue imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy
25. Hypertrophic cardiomyopathy: A 1987 viewpoint
26. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil
27. Assessment of regional early diastolic function using cine magnetic resonance imaging in patients with hypertrophic cardiomyopathy
28. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects
29. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990
30. Risk stratification in hypertrophic cardiomyopathy
31. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients
32. Management of arrhythmias in hypertrophic cardiomyopathy
33. Hypertrophic cardiomyopathy interrelations of clinical manifestations, pathophysiology, and therapy (second of two parts)
34. Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study
35. Myocardial ischemia in patients with hypertrophic cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures
36. Clinical and echocardiographic evaluation of the effects of atrial defibrillation in patients with idiopathic cardiomyopathy
37. Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis
38. Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy
39. Differences in distribution of myocardial abnormalities in patients with obstructive and nonobstructive asymmetric septal hypertrophy (ASH). Light and electron microscopic findings
40. Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS
41. Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy
42. Three autopsy cases of progression to left ventricular dilatation in patients with hypertrophic cardiomyopathy
43. Hypertrophic cardiomyopathy inter-relations of clinical manifestations, pathophysiology, and therapy (first of two parts)
44. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy
45. Small coronary artery disease in cardiomyopathy: Hypertrophic cardiomyopathy resembling dilated cardiomyopathy
46. Ultrastructural changes of blood capillaries in patients with microvascular angina, hypertrophic cardiomyopathy, and dilated cardiomyopathy
47. Luminal narrowing of coronary capillaries in human hypertrophic hearts: An ultrastructural morphometrical study using endomyocardial biopsy specimens